Anti-anxiety drugs (anxiolytics) are medications that reduce anxiety symptoms like panic and excessive worry by slowing down central nervous system activity, often by boosting the calming neurotransmitter GABA.
Anti-anxiety drugs, or anxiolytics, are medications that dial down anxiety symptoms like panic attacks, racing thoughts, and constant worry. They work by slowing the central nervous system, so your brain and body shift out of high alert. The most common ones, benzodiazepines, do this by enhancing the effect of GABA, your brain's main inhibitory (calming) neurotransmitter. More GABA activity means less neural firing, which means less of that jittery, on-edge feeling.
In AP terms, this is a biological treatment for anxiety. Instead of changing how you think (like therapy does), it changes your brain chemistry directly. That makes it a textbook example of the biological perspective on treating psychological disorders, and it's also one of the medical tools people use to manage stress.
Anti-anxiety drugs show up in two spots: topic 8.9 (Treatment of Disorders from the Biological Perspective) and topic 7.4 (Stress and Coping). Under 8.9, they're the go-to example of treating anxiety by altering brain chemistry rather than thought patterns. Under 7.4, they're a pharmaceutical coping strategy, which is exactly where the exam likes to ask about ethical trade-offs. Knowing the GABA mechanism lets you connect a drug to a specific neurotransmitter, which is the kind of biology-to-behavior link AP Psych rewards.
Keep studying AP Psychology Unit 8
GABA and Benzodiazepines (Unit 8)
Anti-anxiety drugs don't calm you out of nowhere. Benzodiazepines work by ramping up GABA, the neurotransmitter that quiets neural firing. Think of GABA as the brain's brake pedal, and anxiolytics press it harder.
Anxiety Disorders and Panic Disorder (Unit 8)
These drugs are the symptom they exist to treat. Anxiety disorders, including panic disorder, are the diagnoses, and anxiolytics are the biological treatment aimed at the excessive fear and worry those disorders produce.
Stress and Coping (Unit 7)
Topic 7.4 frames anti-anxiety drugs as a coping tool, but a contested one. The exam wants you to weigh quick chemical relief against alternatives like exercise or therapy that build longer-term resilience.
Antipsychotic Drugs (Unit 8)
Both are biological treatments, but don't mix them up. Antipsychotics target hallucinations and delusions in disorders like schizophrenia, while anxiolytics target anxiety, and they act on different neurotransmitter systems.
Expect anti-anxiety drugs in multiple-choice stems that test the biological perspective, often by asking you to match the drug to its neurotransmitter (GABA) or to the disorder it treats. A free-response prompt might ask you to apply a biological treatment to a scenario, or to evaluate it against psychological approaches. The ethics angle is a favorite: you may be asked why psychologists challenge relying on pharmaceutical interventions to manage stress instead of behavioral coping strategies. To answer well, name the mechanism, name the disorder, and weigh the drawbacks like dependence or treating symptoms without addressing root causes.
Both are biological treatments, but they treat completely different things. Anti-anxiety drugs (anxiolytics) calm anxiety by boosting GABA. Antipsychotic drugs reduce psychotic symptoms like hallucinations and delusions, mainly by affecting dopamine. If the scenario involves panic and worry, it's anti-anxiety; if it involves a break from reality, it's antipsychotic.
Anti-anxiety drugs, also called anxiolytics, reduce anxiety symptoms by slowing the central nervous system.
Benzodiazepines are the most common type, and they work by enhancing GABA, the brain's main calming neurotransmitter.
On the AP exam, these are the classic example of treating anxiety from the biological perspective (topic 8.9).
Under stress and coping (topic 7.4), they're a pharmaceutical coping strategy that raises ethical questions about over-reliance on medication.
Don't confuse them with antipsychotics, which treat hallucinations and delusions through dopamine rather than anxiety through GABA.
They're medications, also called anxiolytics, that reduce anxiety symptoms like panic and worry by slowing central nervous system activity. The most common type, benzodiazepines, do this by boosting GABA, the brain's inhibitory neurotransmitter.
No. They reduce symptoms by calming the nervous system, but they don't address the underlying causes the way therapy can. That's exactly why some psychologists question relying on them as a stress-management strategy.
Anti-anxiety drugs treat anxiety by boosting GABA, while antipsychotic drugs treat hallucinations and delusions (seen in disorders like schizophrenia) mainly by affecting dopamine. Both are biological treatments, but they target different symptoms and neurotransmitters.
Mainly GABA. Benzodiazepines enhance GABA's effect, which increases inhibition in the brain and produces a calming result. Knowing this drug-to-neurotransmitter link is a common AP test point.
Because the drugs treat symptoms rather than root causes, can lead to dependence, and may replace coping skills that build long-term resilience, like therapy or exercise. The exam uses this ethical tension in the stress and coping unit (topic 7.4).